Skip to main content
. 2022 Aug 4;29(8):5550–5565. doi: 10.3390/curroncol29080438

Figure 1.

Figure 1

Maximum intensity projection (MIP) of 68Ga-DOTATOC before treatment of each patient. (1–8) correspond to patients treated in accordance with the rest of the article.The red arrows in patient 1 show intense uptake in all intra-cranial multifocal meningiomas and mediastinal lymph node metastases, greater than the uptake in the liver (green arrow). The remaining patients (patients 2–8) have multifocal intracranial meninigiomas also showing higher or equal uptake of Ga-DOTATOC in tumor tissue than in healthy liver tissue.